EPISODE · Dec 17, 2021 · 18 MIN
Antibiotic Resistance and What is ESG?
from Sustainability Now · host MSCI ESG Research LLC
Antibiotic resistance is getting more worrisome. It's possible by 2050, antibiotic resistant super bugs could kill three times as many people could a year as during the worst parts of the COVID-19 pandemic . But there may be hope in the development of novel antibiotics. We discuss how this is related to the development of the COVID-19 vaccine. Then we finally put ESG ratings in their rightful place and tell you what they are REALLY used for.The antibiotic story references research from our 2022 ESG Trends which can be viewed here: https://www.msci.com/research/2022-esg-trends-to-watchThe ESG ratings portion references an interactive chart which can be fond here: https://www.msci.com/research/2022-esg-trends-to-watch/esg-ratings-in-rightful-placeHost: Mike DisabatoGuests: Julia Giguere-Morello, ESG Research; Laura Nishikawa, ESG Research
Embed this episode
What this episode covers
Antibiotic resistance is getting more worrisome. It's possible by 2050, antibiotic resistant super bugs could kill three times as many people could a year as during the worst parts of the COVID-19 pandemic . But there may be hope in the development of novel antibiotics. We discuss how this is related to the development of the COVID-19 vaccine. Then we finally put ESG ratings in their rightful place and tell you what they are REALLY used for. The antibiotic story references research from our 2...
NOW PLAYING
Antibiotic Resistance and What is ESG?
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.